Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
23200 | 355 | 45.0 | 75% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
100 | 3 | NEUROSCIENCES//METABOTROPIC GLUTAMATE RECEPTOR//HIPPOCAMPUS | 73970 |
488 | 2 | SIGMA RECEPTOR//NMDA RECEPTOR//PHENCYCLIDINE | 15502 |
23200 | 1 | D CYCLOSERINE//MILACEMIDE//CYCLOSERINE | 355 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | D CYCLOSERINE | authKW | 5405417 | 38% | 47% | 135 |
2 | MILACEMIDE | authKW | 501242 | 4% | 45% | 13 |
3 | CYCLOSERINE | authKW | 324188 | 4% | 27% | 14 |
4 | GERIATR NEUROBEHAV CLIN | address | 172029 | 1% | 100% | 2 |
5 | GLYCINE PRODRUG | authKW | 172029 | 1% | 100% | 2 |
6 | EXPOSURE THERAPY | authKW | 125150 | 6% | 7% | 21 |
7 | EXPOSURE BASED THERAPY | authKW | 114685 | 1% | 67% | 2 |
8 | INTEGRATED MENTAL HLTH CARE PRO PERSONA | address | 114685 | 1% | 67% | 2 |
9 | 2 N PENTYLAMINOACETAMIDE HYDROCHLORIDE | authKW | 86014 | 0% | 100% | 1 |
10 | ACTIVE AVOIDANCE REFLEX | authKW | 86014 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Psychiatry | 2668 | 32% | 0% | 112 |
2 | Neurosciences | 2025 | 44% | 0% | 157 |
3 | Behavioral Sciences | 1499 | 15% | 0% | 53 |
4 | Pharmacology & Pharmacy | 1001 | 32% | 0% | 114 |
5 | Psychology, Clinical | 674 | 10% | 0% | 36 |
6 | Psychology | 440 | 8% | 0% | 29 |
7 | Substance Abuse | 165 | 3% | 0% | 12 |
8 | Psychology, Multidisciplinary | 164 | 5% | 0% | 19 |
9 | Clinical Neurology | 84 | 8% | 0% | 29 |
10 | Psychology, Experimental | 18 | 2% | 0% | 7 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GERIATR NEUROBEHAV CLIN | 172029 | 1% | 100% | 2 |
2 | INTEGRATED MENTAL HLTH CARE PRO PERSONA | 114685 | 1% | 67% | 2 |
3 | ANXIETY DISORDERS PRO PERSONA | 86014 | 0% | 100% | 1 |
4 | ANXIETY PSYCHOTHER Y | 86014 | 0% | 100% | 1 |
5 | BEHAV HLTH BRAIN SCI | 86014 | 0% | 100% | 1 |
6 | CLINICOTOXICOL COORDINATING EARLY WARNIN | 86014 | 0% | 100% | 1 |
7 | ECHEM SCI | 86014 | 0% | 100% | 1 |
8 | ELETTRON PL | 86014 | 0% | 100% | 1 |
9 | MARTINOS MED IMAGING | 86014 | 0% | 100% | 1 |
10 | PHARMACEUT ORION CORP | 86014 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEUROBIOLOGY OF LEARNING AND MEMORY | 8959 | 4% | 1% | 15 |
2 | BIOLOGICAL PSYCHIATRY | 3063 | 5% | 0% | 18 |
3 | LEARNING & MEMORY | 1940 | 2% | 0% | 6 |
4 | DEPRESSION AND ANXIETY | 1897 | 2% | 0% | 6 |
5 | BEHAVIOURAL BRAIN RESEARCH | 1835 | 4% | 0% | 15 |
6 | PSYCHOPHARMACOLOGY | 1804 | 5% | 0% | 16 |
7 | NEUROPSYCHOPHARMACOLOGY | 1682 | 3% | 0% | 10 |
8 | JOURNAL OF PSYCHIATRIC RESEARCH | 1291 | 2% | 0% | 7 |
9 | BEHAVIOUR RESEARCH AND THERAPY | 787 | 2% | 0% | 6 |
10 | CLINICAL PSYCHOLOGIST | 759 | 0% | 1% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | D CYCLOSERINE | 5405417 | 38% | 47% | 135 | Search D+CYCLOSERINE | Search D+CYCLOSERINE |
2 | MILACEMIDE | 501242 | 4% | 45% | 13 | Search MILACEMIDE | Search MILACEMIDE |
3 | CYCLOSERINE | 324188 | 4% | 27% | 14 | Search CYCLOSERINE | Search CYCLOSERINE |
4 | GLYCINE PRODRUG | 172029 | 1% | 100% | 2 | Search GLYCINE+PRODRUG | Search GLYCINE+PRODRUG |
5 | EXPOSURE THERAPY | 125150 | 6% | 7% | 21 | Search EXPOSURE+THERAPY | Search EXPOSURE+THERAPY |
6 | EXPOSURE BASED THERAPY | 114685 | 1% | 67% | 2 | Search EXPOSURE+BASED+THERAPY | Search EXPOSURE+BASED+THERAPY |
7 | 2 N PENTYLAMINOACETAMIDE HYDROCHLORIDE | 86014 | 0% | 100% | 1 | Search 2+N+PENTYLAMINOACETAMIDE+HYDROCHLORIDE | Search 2+N+PENTYLAMINOACETAMIDE+HYDROCHLORIDE |
8 | ACTIVE AVOIDANCE REFLEX | 86014 | 0% | 100% | 1 | Search ACTIVE+AVOIDANCE+REFLEX | Search ACTIVE+AVOIDANCE+REFLEX |
9 | ADMINISTRATION ACUTE AND CHRONIC | 86014 | 0% | 100% | 1 | Search ADMINISTRATION+ACUTE+AND+CHRONIC | Search ADMINISTRATION+ACUTE+AND+CHRONIC |
10 | ANTI INFLAMMATORY ANTIMICROBIAL ACTIVITIES | 86014 | 0% | 100% | 1 | Search ANTI+INFLAMMATORY+ANTIMICROBIAL+ACTIVITIES | Search ANTI+INFLAMMATORY+ANTIMICROBIAL+ACTIVITIES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | OTTO, MW , KREDLOW, MA , SMITS, JAJ , HOFMANN, SG , TOLIN, DF , DE KLEINE, RA , VAN MINNEN, A , EVINS, AE , POLLACK, MH , (2016) ENHANCEMENT OF PSYCHOSOCIAL TREATMENT WITH D-CYCLOSERINE: MODELS, MODERATORS, AND FUTURE DIRECTIONS.BIOLOGICAL PSYCHIATRY. VOL. 80. ISSUE 4. P. 274 -283 | 63 | 77% | 2 |
2 | MYERS, KM , CARLEZON, WA , (2012) D-CYCLOSERINE EFFECTS ON EXTINCTION OF CONDITIONED RESPONSES TO DRUG-RELATED CUES.BIOLOGICAL PSYCHIATRY. VOL. 71. ISSUE 11. P. 947-955 | 37 | 67% | 30 |
3 | HOFMANN, SG , OTTO, MW , POLLACK, MH , SMITS, JA , (2015) D-CYCLOSERINE AUGMENTATION OF COGNITIVE BEHAVIORAL THERAPY FOR ANXIETY DISORDERS: AN UPDATE.CURRENT PSYCHIATRY REPORTS. VOL. 17. ISSUE 1. P. - | 23 | 85% | 18 |
4 | ORI, R , AMOS, T , BERGMAN, H , SOARES-WEISER, K , IPSER, JC , STEIN, DJ , (2015) AUGMENTATION OF COGNITIVE AND BEHAVIOURAL THERAPIES (CBT) WITH D-CYCLOSERINE FOR ANXIETY AND RELATED DISORDERS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 5. P. - | 42 | 53% | 4 |
5 | DE KLEINE, RA , SMITS, JAJ , HENDRIKS, GJ , BECKER, ES , VAN MINNEN, A , (2015) EXTINCTION LEARNING AS A MODERATOR OF D-CYCLOSERINE EFFICACY FOR ENHANCING EXPOSURE THERAPY IN POSTTRAUMATIC STRESS DISORDER.JOURNAL OF ANXIETY DISORDERS. VOL. 34. ISSUE . P. 63 -67 | 24 | 69% | 4 |
6 | NORBERG, MM , KRYSTAL, JH , TOLIN, DF , (2008) A META-ANALYSIS OF D-CYCLOSERINE AND THE FACILITATION OF FEAR EXTINCTION AND EXPOSURE THERAPY.BIOLOGICAL PSYCHIATRY. VOL. 63. ISSUE 12. P. 1118-1126 | 32 | 44% | 230 |
7 | SMITS, JAJ , ROSENFIELD, D , OTTO, MW , POWERS, MB , HOFMANN, SG , TELCH, MJ , POLLACK, MH , TART, CD , (2013) D-CYCLOSERINE ENHANCEMENT OF FEAR EXTINCTION IS SPECIFIC TO SUCCESSFUL EXPOSURE SESSIONS: EVIDENCE FROM THE TREATMENT OF HEIGHT PHOBIA.BIOLOGICAL PSYCHIATRY. VOL. 73. ISSUE 11. P. 1054-1058 | 17 | 85% | 34 |
8 | RODRIGUES, H , FIGUEIRA, I , LOPES, A , GONCALVES, R , MENDLOWICZ, MV , COUTINHO, ESF , VENTURA, P , (2014) DOES D-CYCLOSERINE ENHANCE EXPOSURE THERAPY FOR ANXIETY DISORDERS IN HUMANS? A META-ANALYSIS.PLOS ONE. VOL. 9. ISSUE 7. P. - | 26 | 49% | 27 |
9 | PORTERO-TRESSERRA, M , MARTI-NICOLOVIUS, M , GUILLAZO-BLANCH, G , BOADAS-VAELLO, P , VALE-MARTINEZ, A , (2013) D-CYCLOSERINE IN THE BASOLATERAL AMYGDALA PREVENTS EXTINCTION AND ENHANCES RECONSOLIDATION OF ODOR-REWARD ASSOCIATIVE LEARNING IN RATS.NEUROBIOLOGY OF LEARNING AND MEMORY. VOL. 100. ISSUE . P. 1-11 | 32 | 46% | 7 |
10 | OTTO, MW , BASDEN, SL , MCHUGH, RK , KANTAK, KM , DECKERSBACH, T , CATHER, C , GOFF, DC , HOFMANN, SG , BERRY, AC , SMITS, JAJ , (2009) EFFECTS OF D-CYCLOSERINE ADMINISTRATION ON WEEKLY NONEMOTIONAL MEMORY TASKS IN HEALTHY PARTICIPANTS.PSYCHOTHERAPY AND PSYCHOSOMATICS. VOL. 78. ISSUE 1. P. 49-54 | 19 | 79% | 12 |
Classes with closest relation at Level 1 |